Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by Noloon Nov 15, 2019 6:07pm
178 Views
Post# 30358840

My opinion on today's CC (for what it's worth)

My opinion on today's CC (for what it's worth)First of all, I must say I had the intention to sell 90% of my position this morning and keep 10% as a lottery ticket but decided to keep it all. So, whatever happens from this point forward is my sole responsibility. Not SZLS's management fault but mine. 

CBG posted a great summary below so I'll try not to repeat too much:

1-Legal mumbo jumbo as intro: I noticed that Tripp read the following part a little more slowly so it would be understood: It is recommended not to rely on forward looking statements. Absolutely. But the best way to avoid any backlashes would be to not do any of these forward looking statement. And that's the path JHT seems to have taken. Thank God for this.

2-Small team: they're a small team, working very hard and everything they intend to do takes more time than what they had anticipated at first. I don't believe they are ill intentioned or anything like that but they are a clumsy in regards to investors relation. If they were ill intentioned as some here and on CEO.ca take pleasure to say, they would have stuffed this CC full of those absurd predictions and forward looking statements again but they adapted and chose not to. Wise choice.

3-Telehealth: it's pretty much everything. I don't know how many times Tripp said that word throughout the CC. That will be their tool to penetrate the market and also any large employer groups. 

4-The large HC group: it is not a sales initiative for now. It is a pilot program, nothing more, nothing less. See it as a kind of laboratory for SZLS. the HC group supply patients and SZLS collect data on how to work with these patients. Again, for the immediate future, this won't be a source of revenue. Doesn't mean it won't be useful, though. In fact, it will be crucial for Aristotle development. But cash will have to come from somewhere else.

5-Oncore: their initiative is not a progressive launch with sales slowly building up during the first 6 month period. They will take those 6 months to set up (expect more as usual), then marketing, then launch at long last. So we might end up waiting close to a full year for these guys to contribute. 

6-Small practices:  they are starting to pick up nicely according to Tripp. Does that mean that there actually is revenue coming from those groups? Time will tell. 

7-There may be more HC groups that could join along the way. Good, but nothing real and concrete with that info. 

8-Billing: nothing done since early Q2 but working since October so cash is coming in as we speak. To what level, nobody knows. 

So, plenty of positive things for the future but no hard evidence of success in anything again. Moving forward, one should ask himself/herself if this stock is really what he/she wants as an investment because it is very, very risky. With that in mind, if you have not put your whole future and existence into this, it could be a good gamble. If you've sold your shirt to invest in SZLS, then the shame is on you, not on Tripp or management. 
Bullboard Posts